T1	Participants 83 117	women suffering from schizophrenia
T2	Participants 265 299	women suffering from schizophrenia
T3	Participants 319 580	a placebo-controlled, double-blind, three-time cross-over study using 17beta-estradiol combined with norethisterone acetate for replacement therapy and as an adjunct to a naturalistic maintenance antipsychotic treatment was carried out over a period of 8 months
T4	Participants 582 697	Nineteen women (mean age=38.0 years, SD=9.9 years) with schizophrenia hospitalized for the first time or repeatedly
T5	Participants 1561 1585	women with schizophrenia
